{"nct_id":"NCT04740307","title":"Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2021-03-16","start_date_type":"ACTUAL","primary_completion_date":"2025-07-29","primary_completion_date_type":"ACTUAL","completion_date":"2025-07-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}